BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, April 28, 2025
Breaking News: Trump administration impacts
Breaking News: Trump administration impacts
Breaking News: Trump administration impacts
Breaking News: Trump administration impacts
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Positive preliminary results announced for CholestaGel phase IIa study
May 17, 1996
FO-2546F: ACAT inhibitor from Albophoma yamanashiensis
May 17, 1996
Creative Biomolecules, Stryker extend OP-1 agreement
May 17, 1996
Estraderm MX launched in U.K.
May 10, 1996
Estring approved for marketing in U.S.
May 10, 1996
Muse safety and efficacy reported at urology meeting
May 10, 1996
Sildenafil demonstrates efficacy in erectile dysfunction Rx
May 10, 1996
AI-401 progresses to phase II
May 10, 1996
EU approval granted for Humalog
May 10, 1996
Sandoz synthesizes new antidiabetic agents
May 10, 1996
Previous
1
2
…
1751
1752
1753
1754
1755
1756
1757
1758
1759
1760
1761
1762
Next
RSS